5TC0 | Transferase Transferase Inhibitor | date | Sep 13, 2016 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Structure-Based Optimization Of 1h-Imidazole-2-Carboxamides Kinase Inhibitors Utilizing A Mer Mutant Surrogate | ||||||||||||||
authors | I.D.Hoffman, J.D.Lawson | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Tyrosine-Protein Kinase Mer Chain: A, B Fragment: Unp Residues 570-864 Synonym: Proto-Oncogene C-Mer,Receptor Tyrosine Kinase Mert Ec: 2.7.10.1 Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Mertk, Mer Expression_system: Escherichia Coli Expression_system_taxid: 469008 Expression_system_strain: Bl21(De3) Expression_system_plasmid: Psx71 | ||||||||||||||
symmetry | Space Group: P 1 21 1 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.24 Å | ||||||||||||
ligand | 79Y | enzyme | Transferase E.C.2.7.10.1 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Structure-based optimization of 1H-imidazole-2-carboxamides as Axl kinase inhibitors utilizing a Mer mutant surrogate., Keung W, Boloor A, Brown J, Kiryanov A, Gangloff A, Lawson JD, Skene R, Hoffman I, Atienza J, Kahana J, De Jong R, Farrell P, Balakrishna D, Halkowycz P, Bioorg Med Chem Lett. 2016 Dec 20. pii: S0960-894X(16)31291-4. doi:, 10.1016/j.bmcl.2016.12.024. PMID:28082036 |
Data retrieval |
View 5TC0 in 3D |
Visual 3D analysis of 5TC0 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 5TC0 |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |